Kiniksa Pharmaceuticals International Plc (KNSA)
75.79
+0.57
(+0.76%)
USD |
NASDAQ |
Oct 02, 16:00
75.72
-0.07
(-0.09%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International EPS Diluted (Quarterly) : 0.305 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.305 |
| March 31, 2026 | 0.2741 |
| December 31, 2025 | 0.1741 |
| September 30, 2025 | 0.2303 |
| June 30, 2025 | 0.2288 |
| March 31, 2025 | 0.1121 |
| December 31, 2024 | -0.1229 |
| September 30, 2024 | -0.177 |
| June 30, 2024 | -0.055 |
| March 31, 2024 | -0.2506 |
| December 31, 2023 | 0.3473 |
| September 30, 2023 | -0.1974 |
| June 30, 2023 | 0.209 |
| March 31, 2023 | -0.1759 |
| December 31, 2022 | 0.0625 |
| September 30, 2022 | 3.176 |
| June 30, 2022 | -0.2884 |
| March 31, 2022 | -0.3646 |
| December 31, 2021 | -0.5268 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.4448 |
| June 30, 2021 | -0.6077 |
| March 31, 2021 | -0.7248 |
| December 31, 2020 | -0.7884 |
| September 30, 2020 | -0.6646 |
| June 30, 2020 | -0.647 |
| March 31, 2020 | -0.4775 |
| December 31, 2019 | -0.5793 |
| September 30, 2019 | -0.4935 |
| June 30, 2019 | -0.6827 |
| March 31, 2019 | -1.272 |
| December 31, 2018 | -0.8604 |
| September 30, 2018 | -0.4934 |
| June 30, 2018 | -0.4097 |
| March 31, 2018 | -0.3232 |
| December 31, 2017 | -0.6613 |
| September 30, 2017 | -0.3242 |
| June 30, 2017 | -0.2266 |
| March 31, 2017 | -0.0999 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.1472 |
| Scancell Holdings Plc | -- |
| OptiBiotix Health Plc | -- |
| Adaptimmune Therapeutics Plc | -0.1163 |
| Oxford Biomedica Plc | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 25.43M |
| Revenue (Quarterly) | 243.60M |
| Total Expenses (Quarterly) | 218.17M |
| Enterprise Value | 5.393B |
| Gross Profit Margin (Quarterly) | 54.10% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 1.30% |
| Operating Earnings Yield | 1.62% |
| Normalized Earnings Yield | 1.298 |